1 Study Coverage
1.1 Direct Oral Anticoagulant Product Introduction
1.2 Market by Type
1.2.1 Global Direct Oral Anticoagulant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Apixaban
1.2.3 Dabigatran
1.2.4 Rivaroxaban
1.2.5 Edoxaban
1.3 Market by Application
1.3.1 Global Direct Oral Anticoagulant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals Pharmacies
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Direct Oral Anticoagulant Sales Estimates and Forecasts 2017-2028
2.2 Global Direct Oral Anticoagulant Revenue Estimates and Forecasts 2017-2028
2.3 Global Direct Oral Anticoagulant Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Direct Oral Anticoagulant Sales by Region
2.4.1 Global Direct Oral Anticoagulant Sales by Region (2017-2022)
2.4.2 Global Sales Direct Oral Anticoagulant by Region (2023-2028)
2.5 Global Direct Oral Anticoagulant Revenue by Region
2.5.1 Global Direct Oral Anticoagulant Revenue by Region (2017-2022)
2.5.2 Global Direct Oral Anticoagulant Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Direct Oral Anticoagulant Sales by Manufacturers
3.1.1 Global Top Direct Oral Anticoagulant Manufacturers by Sales (2017-2022)
3.1.2 Global Direct Oral Anticoagulant Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Direct Oral Anticoagulant in 2021
3.2 Global Direct Oral Anticoagulant Revenue by Manufacturers
3.2.1 Global Direct Oral Anticoagulant Revenue by Manufacturers (2017-2022)
3.2.2 Global Direct Oral Anticoagulant Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Direct Oral Anticoagulant Revenue in 2021
3.3 Global Direct Oral Anticoagulant Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Direct Oral Anticoagulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Direct Oral Anticoagulant Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Direct Oral Anticoagulant Sales by Type
4.1.1 Global Direct Oral Anticoagulant Historical Sales by Type (2017-2022)
4.1.2 Global Direct Oral Anticoagulant Forecasted Sales by Type (2023-2028)
4.1.3 Global Direct Oral Anticoagulant Sales Market Share by Type (2017-2028)
4.2 Global Direct Oral Anticoagulant Revenue by Type
4.2.1 Global Direct Oral Anticoagulant Historical Revenue by Type (2017-2022)
4.2.2 Global Direct Oral Anticoagulant Forecasted Revenue by Type (2023-2028)
4.2.3 Global Direct Oral Anticoagulant Revenue Market Share by Type (2017-2028)
4.3 Global Direct Oral Anticoagulant Price by Type
4.3.1 Global Direct Oral Anticoagulant Price by Type (2017-2022)
4.3.2 Global Direct Oral Anticoagulant Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Direct Oral Anticoagulant Sales by Application
5.1.1 Global Direct Oral Anticoagulant Historical Sales by Application (2017-2022)
5.1.2 Global Direct Oral Anticoagulant Forecasted Sales by Application (2023-2028)
5.1.3 Global Direct Oral Anticoagulant Sales Market Share by Application (2017-2028)
5.2 Global Direct Oral Anticoagulant Revenue by Application
5.2.1 Global Direct Oral Anticoagulant Historical Revenue by Application (2017-2022)
5.2.2 Global Direct Oral Anticoagulant Forecasted Revenue by Application (2023-2028)
5.2.3 Global Direct Oral Anticoagulant Revenue Market Share by Application (2017-2028)
5.3 Global Direct Oral Anticoagulant Price by Application
5.3.1 Global Direct Oral Anticoagulant Price by Application (2017-2022)
5.3.2 Global Direct Oral Anticoagulant Price Forecast by Application (2023-2028)
6 North America
6.1 North America Direct Oral Anticoagulant Market Size by Type
6.1.1 North America Direct Oral Anticoagulant Sales by Type (2017-2028)
6.1.2 North America Direct Oral Anticoagulant Revenue by Type (2017-2028)
6.2 North America Direct Oral Anticoagulant Market Size by Application
6.2.1 North America Direct Oral Anticoagulant Sales by Application (2017-2028)
6.2.2 North America Direct Oral Anticoagulant Revenue by Application (2017-2028)
6.3 North America Direct Oral Anticoagulant Market Size by Country
6.3.1 North America Direct Oral Anticoagulant Sales by Country (2017-2028)
6.3.2 North America Direct Oral Anticoagulant Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Direct Oral Anticoagulant Market Size by Type
7.1.1 Europe Direct Oral Anticoagulant Sales by Type (2017-2028)
7.1.2 Europe Direct Oral Anticoagulant Revenue by Type (2017-2028)
7.2 Europe Direct Oral Anticoagulant Market Size by Application
7.2.1 Europe Direct Oral Anticoagulant Sales by Application (2017-2028)
7.2.2 Europe Direct Oral Anticoagulant Revenue by Application (2017-2028)
7.3 Europe Direct Oral Anticoagulant Market Size by Country
7.3.1 Europe Direct Oral Anticoagulant Sales by Country (2017-2028)
7.3.2 Europe Direct Oral Anticoagulant Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Direct Oral Anticoagulant Market Size by Type
8.1.1 Asia Pacific Direct Oral Anticoagulant Sales by Type (2017-2028)
8.1.2 Asia Pacific Direct Oral Anticoagulant Revenue by Type (2017-2028)
8.2 Asia Pacific Direct Oral Anticoagulant Market Size by Application
8.2.1 Asia Pacific Direct Oral Anticoagulant Sales by Application (2017-2028)
8.2.2 Asia Pacific Direct Oral Anticoagulant Revenue by Application (2017-2028)
8.3 Asia Pacific Direct Oral Anticoagulant Market Size by Region
8.3.1 Asia Pacific Direct Oral Anticoagulant Sales by Region (2017-2028)
8.3.2 Asia Pacific Direct Oral Anticoagulant Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Direct Oral Anticoagulant Market Size by Type
9.1.1 Latin America Direct Oral Anticoagulant Sales by Type (2017-2028)
9.1.2 Latin America Direct Oral Anticoagulant Revenue by Type (2017-2028)
9.2 Latin America Direct Oral Anticoagulant Market Size by Application
9.2.1 Latin America Direct Oral Anticoagulant Sales by Application (2017-2028)
9.2.2 Latin America Direct Oral Anticoagulant Revenue by Application (2017-2028)
9.3 Latin America Direct Oral Anticoagulant Market Size by Country
9.3.1 Latin America Direct Oral Anticoagulant Sales by Country (2017-2028)
9.3.2 Latin America Direct Oral Anticoagulant Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Direct Oral Anticoagulant Market Size by Type
10.1.1 Middle East and Africa Direct Oral Anticoagulant Sales by Type (2017-2028)
10.1.2 Middle East and Africa Direct Oral Anticoagulant Revenue by Type (2017-2028)
10.2 Middle East and Africa Direct Oral Anticoagulant Market Size by Application
10.2.1 Middle East and Africa Direct Oral Anticoagulant Sales by Application (2017-2028)
10.2.2 Middle East and Africa Direct Oral Anticoagulant Revenue by Application (2017-2028)
10.3 Middle East and Africa Direct Oral Anticoagulant Market Size by Country
10.3.1 Middle East and Africa Direct Oral Anticoagulant Sales by Country (2017-2028)
10.3.2 Middle East and Africa Direct Oral Anticoagulant Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bristol-Meyers Squibb Co
11.1.1 Bristol-Meyers Squibb Co Corporation Information
11.1.2 Bristol-Meyers Squibb Co Overview
11.1.3 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bristol-Meyers Squibb Co Recent Developments
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Corporation Information
11.2.2 Pfizer Inc. Overview
11.2.3 Pfizer Inc. Direct Oral Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Inc. Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Inc. Recent Developments
11.3 Boehringer Ingelheim Pharmaceuticals, Inc
11.3.1 Boehringer Ingelheim Pharmaceuticals, Inc Corporation Information
11.3.2 Boehringer Ingelheim Pharmaceuticals, Inc Overview
11.3.3 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Pharmaceuticals, Inc Recent Developments
11.4 Janssen Pharmaceuticals, Inc.
11.4.1 Janssen Pharmaceuticals, Inc. Corporation Information
11.4.2 Janssen Pharmaceuticals, Inc. Overview
11.4.3 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Janssen Pharmaceuticals, Inc. Recent Developments
11.5 Bayer AG
11.5.1 Bayer AG Corporation Information
11.5.2 Bayer AG Overview
11.5.3 Bayer AG Direct Oral Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bayer AG Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bayer AG Recent Developments
11.6 Teva Pharmaceutical Industries Ltd
11.6.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.6.2 Teva Pharmaceutical Industries Ltd Overview
11.6.3 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.7 Pab Organics Private Limited
11.7.1 Pab Organics Private Limited Corporation Information
11.7.2 Pab Organics Private Limited Overview
11.7.3 Pab Organics Private Limited Direct Oral Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Pab Organics Private Limited Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pab Organics Private Limited Recent Developments
11.8 Daiichi Sankyo Company, Limited
11.8.1 Daiichi Sankyo Company, Limited Corporation Information
11.8.2 Daiichi Sankyo Company, Limited Overview
11.8.3 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Daiichi Sankyo Company, Limited Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Direct Oral Anticoagulant Industry Chain Analysis
12.2 Direct Oral Anticoagulant Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Direct Oral Anticoagulant Production Mode & Process
12.4 Direct Oral Anticoagulant Sales and Marketing
12.4.1 Direct Oral Anticoagulant Sales Channels
12.4.2 Direct Oral Anticoagulant Distributors
12.5 Direct Oral Anticoagulant Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Direct Oral Anticoagulant Industry Trends
13.2 Direct Oral Anticoagulant Market Drivers
13.3 Direct Oral Anticoagulant Market Challenges
13.4 Direct Oral Anticoagulant Market Restraints
14 Key Findings in The Global Direct Oral Anticoagulant Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Direct Oral Anticoagulant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Apixaban
Table 3. Major Manufacturers of Dabigatran
Table 4. Major Manufacturers of Rivaroxaban
Table 5. Major Manufacturers of Edoxaban
Table 6. Global Direct Oral Anticoagulant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Direct Oral Anticoagulant Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Direct Oral Anticoagulant Sales by Region (2017-2022) & (MT)
Table 9. Global Direct Oral Anticoagulant Sales Market Share by Region (2017-2022)
Table 10. Global Direct Oral Anticoagulant Sales by Region (2023-2028) & (MT)
Table 11. Global Direct Oral Anticoagulant Sales Market Share by Region (2023-2028)
Table 12. Global Direct Oral Anticoagulant Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Direct Oral Anticoagulant Revenue Market Share by Region (2017-2022)
Table 14. Global Direct Oral Anticoagulant Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Direct Oral Anticoagulant Revenue Market Share by Region (2023-2028)
Table 16. Global Direct Oral Anticoagulant Sales by Manufacturers (2017-2022) & (MT)
Table 17. Global Direct Oral Anticoagulant Sales Share by Manufacturers (2017-2022)
Table 18. Global Direct Oral Anticoagulant Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Direct Oral Anticoagulant Revenue Share by Manufacturers (2017-2022)
Table 20. Direct Oral Anticoagulant Price by Manufacturers (2017-2022) &(USD/Kg)
Table 21. Global Direct Oral Anticoagulant Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Direct Oral Anticoagulant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Direct Oral Anticoagulant as of 2021)
Table 23. Direct Oral Anticoagulant Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Direct Oral Anticoagulant Product Offered
Table 25. Date of Manufacturers Enter into Direct Oral Anticoagulant Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT)
Table 28. Global Direct Oral Anticoagulant Sales by Type (2023-2028) & (MT)
Table 29. Global Direct Oral Anticoagulant Sales Share by Type (2017-2022)
Table 30. Global Direct Oral Anticoagulant Sales Share by Type (2023-2028)
Table 31. Global Direct Oral Anticoagulant Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Direct Oral Anticoagulant Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Direct Oral Anticoagulant Revenue Share by Type (2017-2022)
Table 34. Global Direct Oral Anticoagulant Revenue Share by Type (2023-2028)
Table 35. Direct Oral Anticoagulant Price by Type (2017-2022) & (USD/Kg)
Table 36. Global Direct Oral Anticoagulant Price Forecast by Type (2023-2028) & (USD/Kg)
Table 37. Global Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT)
Table 38. Global Direct Oral Anticoagulant Sales by Application (2023-2028) & (MT)
Table 39. Global Direct Oral Anticoagulant Sales Share by Application (2017-2022)
Table 40. Global Direct Oral Anticoagulant Sales Share by Application (2023-2028)
Table 41. Global Direct Oral Anticoagulant Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Direct Oral Anticoagulant Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Direct Oral Anticoagulant Revenue Share by Application (2017-2022)
Table 44. Global Direct Oral Anticoagulant Revenue Share by Application (2023-2028)
Table 45. Direct Oral Anticoagulant Price by Application (2017-2022) & (USD/Kg)
Table 46. Global Direct Oral Anticoagulant Price Forecast by Application (2023-2028) & (USD/Kg)
Table 47. North America Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT)
Table 48. North America Direct Oral Anticoagulant Sales by Type (2023-2028) & (MT)
Table 49. North America Direct Oral Anticoagulant Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Direct Oral Anticoagulant Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT)
Table 52. North America Direct Oral Anticoagulant Sales by Application (2023-2028) & (MT)
Table 53. North America Direct Oral Anticoagulant Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Direct Oral Anticoagulant Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Direct Oral Anticoagulant Sales by Country (2017-2022) & (MT)
Table 56. North America Direct Oral Anticoagulant Sales by Country (2023-2028) & (MT)
Table 57. North America Direct Oral Anticoagulant Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Direct Oral Anticoagulant Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT)
Table 60. Europe Direct Oral Anticoagulant Sales by Type (2023-2028) & (MT)
Table 61. Europe Direct Oral Anticoagulant Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Direct Oral Anticoagulant Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT)
Table 64. Europe Direct Oral Anticoagulant Sales by Application (2023-2028) & (MT)
Table 65. Europe Direct Oral Anticoagulant Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Direct Oral Anticoagulant Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Direct Oral Anticoagulant Sales by Country (2017-2022) & (MT)
Table 68. Europe Direct Oral Anticoagulant Sales by Country (2023-2028) & (MT)
Table 69. Europe Direct Oral Anticoagulant Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Direct Oral Anticoagulant Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT)
Table 72. Asia Pacific Direct Oral Anticoagulant Sales by Type (2023-2028) & (MT)
Table 73. Asia Pacific Direct Oral Anticoagulant Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Direct Oral Anticoagulant Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT)
Table 76. Asia Pacific Direct Oral Anticoagulant Sales by Application (2023-2028) & (MT)
Table 77. Asia Pacific Direct Oral Anticoagulant Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Direct Oral Anticoagulant Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Direct Oral Anticoagulant Sales by Region (2017-2022) & (MT)
Table 80. Asia Pacific Direct Oral Anticoagulant Sales by Region (2023-2028) & (MT)
Table 81. Asia Pacific Direct Oral Anticoagulant Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Direct Oral Anticoagulant Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT)
Table 84. Latin America Direct Oral Anticoagulant Sales by Type (2023-2028) & (MT)
Table 85. Latin America Direct Oral Anticoagulant Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Direct Oral Anticoagulant Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT)
Table 88. Latin America Direct Oral Anticoagulant Sales by Application (2023-2028) & (MT)
Table 89. Latin America Direct Oral Anticoagulant Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Direct Oral Anticoagulant Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Direct Oral Anticoagulant Sales by Country (2017-2022) & (MT)
Table 92. Latin America Direct Oral Anticoagulant Sales by Country (2023-2028) & (MT)
Table 93. Latin America Direct Oral Anticoagulant Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Direct Oral Anticoagulant Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT)
Table 96. Middle East and Africa Direct Oral Anticoagulant Sales by Type (2023-2028) & (MT)
Table 97. Middle East and Africa Direct Oral Anticoagulant Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Direct Oral Anticoagulant Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT)
Table 100. Middle East and Africa Direct Oral Anticoagulant Sales by Application (2023-2028) & (MT)
Table 101. Middle East and Africa Direct Oral Anticoagulant Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Direct Oral Anticoagulant Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Direct Oral Anticoagulant Sales by Country (2017-2022) & (MT)
Table 104. Middle East and Africa Direct Oral Anticoagulant Sales by Country (2023-2028) & (MT)
Table 105. Middle East and Africa Direct Oral Anticoagulant Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Direct Oral Anticoagulant Revenue by Country (2023-2028) & (US$ Million)
Table 107. Bristol-Meyers Squibb Co Corporation Information
Table 108. Bristol-Meyers Squibb Co Description and Major Businesses
Table 109. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 110. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Bristol-Meyers Squibb Co Recent Developments
Table 112. Pfizer Inc. Corporation Information
Table 113. Pfizer Inc. Description and Major Businesses
Table 114. Pfizer Inc. Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 115. Pfizer Inc. Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Pfizer Inc. Recent Developments
Table 117. Boehringer Ingelheim Pharmaceuticals, Inc Corporation Information
Table 118. Boehringer Ingelheim Pharmaceuticals, Inc Description and Major Businesses
Table 119. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 120. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Boehringer Ingelheim Pharmaceuticals, Inc Recent Developments
Table 122. Janssen Pharmaceuticals, Inc. Corporation Information
Table 123. Janssen Pharmaceuticals, Inc. Description and Major Businesses
Table 124. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 125. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Janssen Pharmaceuticals, Inc. Recent Developments
Table 127. Bayer AG Corporation Information
Table 128. Bayer AG Description and Major Businesses
Table 129. Bayer AG Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 130. Bayer AG Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Bayer AG Recent Developments
Table 132. Teva Pharmaceutical Industries Ltd Corporation Information
Table 133. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 134. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 135. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Teva Pharmaceutical Industries Ltd Recent Developments
Table 137. Pab Organics Private Limited Corporation Information
Table 138. Pab Organics Private Limited Description and Major Businesses
Table 139. Pab Organics Private Limited Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 140. Pab Organics Private Limited Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Pab Organics Private Limited Recent Developments
Table 142. Daiichi Sankyo Company, Limited Corporation Information
Table 143. Daiichi Sankyo Company, Limited Description and Major Businesses
Table 144. Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 145. Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Daiichi Sankyo Company, Limited Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Direct Oral Anticoagulant Distributors List
Table 150. Direct Oral Anticoagulant Customers List
Table 151. Direct Oral Anticoagulant Market Trends
Table 152. Direct Oral Anticoagulant Market Drivers
Table 153. Direct Oral Anticoagulant Market Challenges
Table 154. Direct Oral Anticoagulant Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Direct Oral Anticoagulant Product Picture
Figure 3. Global Direct Oral Anticoagulant Market Share by Type in 2021 & 2028
Figure 3. Apixaban Product Picture
Figure 4. Dabigatran Product Picture
Figure 5. Rivaroxaban Product Picture
Figure 6. Edoxaban Product Picture
Figure 7. Global Direct Oral Anticoagulant Market Share by Application in 2021 & 2028
Figure 8. Hospitals Pharmacies
Figure 9. Drug Stores
Figure 10. Online Pharmacies
Figure 11. Direct Oral Anticoagulant Report Years Considered
Figure 12. Global Direct Oral Anticoagulant Sales 2017-2028 (MT)
Figure 13. Global Direct Oral Anticoagulant Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Direct Oral Anticoagulant Revenue 2017-2028 (US$ Million)
Figure 15. Global Direct Oral Anticoagulant Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Direct Oral Anticoagulant Sales Market Share by Region (2017-2022)
Figure 17. Global Direct Oral Anticoagulant Sales Market Share by Region (2023-2028)
Figure 18. North America Direct Oral Anticoagulant Sales YoY (2017-2028) & (MT)
Figure 19. North America Direct Oral Anticoagulant Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Direct Oral Anticoagulant Sales YoY (2017-2028) & (MT)
Figure 21. Europe Direct Oral Anticoagulant Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Direct Oral Anticoagulant Sales YoY (2017-2028) & (MT)
Figure 23. Asia-Pacific Direct Oral Anticoagulant Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Direct Oral Anticoagulant Sales YoY (2017-2028) & (MT)
Figure 25. Latin America Direct Oral Anticoagulant Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Direct Oral Anticoagulant Sales YoY (2017-2028) & (MT)
Figure 27. Middle East & Africa Direct Oral Anticoagulant Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Direct Oral Anticoagulant Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Direct Oral Anticoagulant in the World: Market Share by Direct Oral Anticoagulant Revenue in 2021
Figure 30. Global Direct Oral Anticoagulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Direct Oral Anticoagulant Sales Market Share by Type (2017-2028)
Figure 32. Global Direct Oral Anticoagulant Revenue Market Share by Type (2017-2028)
Figure 33. Global Direct Oral Anticoagulant Sales Market Share by Application (2017-2028)
Figure 34. Global Direct Oral Anticoagulant Revenue Market Share by Application (2017-2028)
Figure 35. North America Direct Oral Anticoagulant Sales Market Share by Type (2017-2028)
Figure 36. North America Direct Oral Anticoagulant Revenue Market Share by Type (2017-2028)
Figure 37. North America Direct Oral Anticoagulant Sales Market Share by Application (2017-2028)
Figure 38. North America Direct Oral Anticoagulant Revenue Market Share by Application (2017-2028)
Figure 39. North America Direct Oral Anticoagulant Sales Share by Country (2017-2028)
Figure 40. North America Direct Oral Anticoagulant Revenue Share by Country (2017-2028)
Figure 41. U.S. Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Direct Oral Anticoagulant Sales Market Share by Type (2017-2028)
Figure 44. Europe Direct Oral Anticoagulant Revenue Market Share by Type (2017-2028)
Figure 45. Europe Direct Oral Anticoagulant Sales Market Share by Application (2017-2028)
Figure 46. Europe Direct Oral Anticoagulant Revenue Market Share by Application (2017-2028)
Figure 47. Europe Direct Oral Anticoagulant Sales Share by Country (2017-2028)
Figure 48. Europe Direct Oral Anticoagulant Revenue Share by Country (2017-2028)
Figure 49. Germany Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 50. France Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Direct Oral Anticoagulant Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Direct Oral Anticoagulant Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Direct Oral Anticoagulant Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Direct Oral Anticoagulant Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Direct Oral Anticoagulant Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Direct Oral Anticoagulant Revenue Share by Region (2017-2028)
Figure 60. China Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 63. India Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Direct Oral Anticoagulant Sales Market Share by Type (2017-2028)
Figure 71. Latin America Direct Oral Anticoagulant Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Direct Oral Anticoagulant Sales Market Share by Application (2017-2028)
Figure 73. Latin America Direct Oral Anticoagulant Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Direct Oral Anticoagulant Sales Share by Country (2017-2028)
Figure 75. Latin America Direct Oral Anticoagulant Revenue Share by Country (2017-2028)
Figure 76. Mexico Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Direct Oral Anticoagulant Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Direct Oral Anticoagulant Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Direct Oral Anticoagulant Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Direct Oral Anticoagulant Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Direct Oral Anticoagulant Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Direct Oral Anticoagulant Revenue Share by Country (2017-2028)
Figure 85. Turkey Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 87. U.A.E Direct Oral Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 88. Direct Oral Anticoagulant Value Chain
Figure 89. Direct Oral Anticoagulant Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
